The present invention relates to the field of nuclear medicine and molecular imaging as well as targeted therapy and targeted radiotherapy, i.e. radiopharmaceuticals for imaging and targeted radiotherapy using metal ion radionuclides in combination with chelators that are functionalized with targeting vectors or additional signalling units.
本发明涉及核医学、分子成像、以及靶向治疗和靶向放射治疗领域,即利用功能化靶向载体或额外信号单元的
螯合剂与
金属离子放射性核素结合的放射性药物,用于成像和靶向放射治疗。